Memphis Pharmaceuticals
- 345.00 EGP
- -11.70
- -3.28%
Memphis Pharmaceuticals Stock Overview
View Company ProfileStock Summary
| Last Price (EGP) | 345.00 |
| Prev. Close | 356.700 |
| Day Range | 345.00 - 360.80 |
| 52WK range | |
| Turnover (M EGP) | 70.68 |
| Volume (M) | 0.20 |
| Number of Trades | 953 |
| Market Cap (M EGP) | 8,114.92 |
| Change in Market Cap (M EGP) | |
| VWAP (EGP) | 350.36 |
| EPS (TTM) | -- |
| EX-Dividend Date | |
| Dividend | |
| Dividend Yield (%) | |
| Beta | |
| 30D Avg Volume | |
| 30D Avg Turnover(M EGP) | |
| Outstanding Shares | |
| Free Float Shares | |
| Free Float % |
Stock Performance
Stock Highlights
| Highest Market Cap | |
| Date of Highest Mkt. Cap | |
| Lowest Market Cap | |
| Date of Lowest Mkt. Cap |
Earnings Progress
News
More Company News
Memphis Pharmaceutical’s shareholders approve company’s...
Cairo – Mubasher: The extraordinary general assembly (EGM) of Memphis Pharmaceutical and Chemical Industries has approved the continuity of the company’s...
Memphis Pharmaceutical’s board approves capital raise
Cairo – Mubasher: Memphis Pharmaceutical and Chemical Industries’ board of directors approved increasing the company’s issued and paid-up...
Memphis Pharmaceutical approves financing to pay off...
Cairo – Mubasher: The board of directors of Memphis Pharmaceutical and Chemical Industries has approved by circulation the financing package provided...
Memphis Pharmaceutical’s annual profits climb 77%
Cairo – Mubasher: Memphis Pharmaceutical and Chemical Industries’ adjusted financial statements for fiscal year (FY) 2021/2022 indicated a...
Memphis Pharmaceutical targets EGP 50m profits in FY22/23
Cairo – Mubasher: Memphis Pharmaceutical and Chemical Industries plans to achieve net profits before tax worth EGP 50 million in fiscal year (FY)...
